PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PSTV)
CUSIP: 72941H509
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 179,252,507
- Total 13F shares
- 101,711
- Share change
- +101,711
- Total reported value
- $205,455
- Price per share
- $2.02
- Number of holders
- 7
- Value change
- +$205,455
- Number of buys
- 7
Quarterly Holders Quick Answers
What is CUSIP 72941H509?
CUSIP 72941H509 identifies PSTV - PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q3 2023
Recent filing periods for CUSIP 72941H509:
Top shareholders of PSTV - PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
—
class O/S missing
|
1,092,953
|
$316,956 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
—
class O/S missing
|
264,310
|
$77,000 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
255,148
|
$73,993 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
—
class O/S missing
|
104,427
|
$30,284 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
69,669
|
$20,000 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
—
class O/S missing
|
57,581
|
$16,698 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
—
class O/S missing
|
34,414
|
$9,980 | — | 31 Mar 2023 | |
| GREAT VALLEY ADVISOR GROUP, INC. |
13F
|
Company |
—
class O/S missing
|
33,600
|
$9,744 | — | 31 Mar 2023 | |
| Creative Planning |
13F
|
Company |
—
class O/S missing
|
33,540
|
$9,727 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
—
class O/S missing
|
32,100
|
$9,309 | — | 31 Mar 2023 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
—
class O/S missing
|
23,449
|
$6,800 | — | 31 Mar 2023 | |
| Ashton Thomas Private Wealth, LLC |
13F
|
Company |
—
class O/S missing
|
12,230
|
$3,547 | — | 31 Mar 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
—
class O/S missing
|
9,056
|
$3,000 | — | 31 Mar 2023 | |
| FMR LLC |
13F
|
Company |
—
class O/S missing
|
2,000
|
$580 | — | 31 Mar 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
—
class O/S missing
|
2,000
|
$580 | — | 31 Mar 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
—
class O/S missing
|
234
|
$68 | — | 31 Mar 2023 | |
| UMB Bank, n.a. |
13F
|
Company |
—
class O/S missing
|
54
|
$16 | — | 31 Mar 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
—
class O/S missing
|
21
|
$6 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
—
class O/S missing
|
13
|
$4 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
—
class O/S missing
|
10
|
$3 | — | 31 Mar 2023 | |
| Allworth Financial LP |
13F
|
Company |
—
class O/S missing
|
1
|
$1 | — | 31 Mar 2023 |
Institutional Holders of PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PSTV) as of Q2 2023
As of 30 Jun 2023,
PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PSTV) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
101,711 shares.
The largest 7 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., Tower Research Capital LLC (TRC), OSAIC HOLDINGS, INC., WELLS FARGO & COMPANY/MN, and GROUP ONE TRADING, L.P..
This page lists
7
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q4 2025 Across Filers
Q4 2025 holders
27
Q2 2023 holders
7
Holder diff
-20
| Investor | Q4 2025 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.